These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32385545)

  • 1. Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.
    Yoon HY; Ahn MH; Yee J; Lee N; Han JM; Gwak HS
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1053-1058. PubMed ID: 32385545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy.
    Wang C; Wang P; Yang LP; Pan J; Yang X; Ma HY
    Epilepsy Res; 2017 May; 132():64-69. PubMed ID: 28315807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.
    Tan L; Yu JT; Sun YP; Ou JR; Song JH; Yu Y
    Clin Neurol Neurosurg; 2010 May; 112(4):320-3. PubMed ID: 20089352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy.
    Song C; Li X; Mao P; Song W; Liu L; Zhang Y
    Eur J Hosp Pharm; 2022 Jul; 29(4):198-201. PubMed ID: 32868386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy.
    Ma B; Yang K; Li X; Su N; Yu T; Zou Y; Xu X; Wang F; Cheng J; Yan Z; Chen T; Zhang L
    Ther Drug Monit; 2024 Aug; 46(4):503-511. PubMed ID: 38287884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.
    Kiang TK; Ho PC; Anari MR; Tong V; Abbott FS; Chang TK
    Toxicol Sci; 2006 Dec; 94(2):261-71. PubMed ID: 16945988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of CYP2C9-status guided valproic acid therapy in children.
    Bűdi T; Tóth K; Nagy A; Szever Z; Kiss Á; Temesvári M; Háfra E; Garami M; Tapodi A; Monostory K
    Epilepsia; 2015 Jun; 56(6):849-55. PubMed ID: 25967074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data.
    Smith RL; Haslemo T; Refsum H; Molden E
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1099-104. PubMed ID: 27353638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.
    Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K
    Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury.
    Sun Y; Yu J; Yuan Q; Wu X; Wu X; Hu J
    Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):85. PubMed ID: 28841884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
    Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH
    Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-Analysis.
    Milosavljevic F; Manojlovic M; Matkovic L; Molden E; Ingelman-Sundberg M; Leucht S; Jukic MM
    JAMA Netw Open; 2024 Aug; 7(8):e2425593. PubMed ID: 39115847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.
    Guo Y; Hu C; He X; Qiu F; Zhao L
    Drug Metab Pharmacokinet; 2012; 27(5):536-42. PubMed ID: 23099353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy.
    Gidal BE; Pitterle ME; Spencer NW; Maly MM
    J Clin Pharm Ther; 1995 Aug; 20(4):215-9. PubMed ID: 8557785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between plasma ammonia level and serum trough concentration of free valproic acid in patients with epilepsy.
    Itoh H; Suzuki Y; Fujisaki K; Sato Y; Takeyama M
    Biol Pharm Bull; 2012; 35(6):971-4. PubMed ID: 22687541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of
    Zheng XX; You YX; Zhao LL; Du Y; Xu SQ; Tang DQ
    Pharmacogenomics; 2023 Feb; 24(3):153-162. PubMed ID: 36718958
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
    Zhu X; Li X; Zhang T; Zhao L
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):628-634. PubMed ID: 29791065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.
    Chu XM; Zhang LF; Wang GJ; Zhang SN; Zhou JH; Hao HP
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1395-401. PubMed ID: 22476391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.